UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
NOTICE OF EFFECTIVENESS
Effective Date:
December 19, 2017
Form:
F-1
CIK:
0001444192
Company Name:
Acasti Pharma Inc.
File Number:
333-220755